The Immunostimulatory Effect of MIL-101(Al)-NH2 In Vivo and Its Potential to Overcome Bacterial Resistance to Penicillin Enhanced by Hypericin-Induced Photodynamic Therapy
The increasing prevalence of multidrug-resistant bacteria necessitates alternative therapeutic strategies that combine antimicrobial efficacy with immunomodulatory properties. Here, we report the immunostimulatory activity and antibacterial potential of the amino-functionalized metal-organic framework MIL-101(Al)-NH<sub>2</sub> as a carrier for penicillin (PEN) and hypericin (Hyp), a photodynamically active compound. Structural and physicochemical characterization confirmed successful encapsulation of PEN, Hyp, and their combination within MIL-101(Al)-NH<sub>2</sub>, with distinct effects on porosity, release kinetics, and thermal stability. Drug release studies revealed rapid Hyp liberation triggered by serum components, whereas PEN exhibited a biphasic, diffusion-controlled profile. Using a quail chorioallantoic membrane (CAM) model, we demonstrated that MIL-101(Al)-NH<sub>2</sub> enhances interferon-α expression, indicating intrinsic immunostimulatory activity, and that Hyp-loaded systems promote angiogenic responses. In a bacterial infection CAM model, MIL-101(Al)-NH<sub>2</sub> carriers loaded with Hyp or Hyp/PEN induced immunomodulatory changes and, upon photodynamic activation, inhibited bacterial growth. While Gram-negative <i>Escherichia coli</i> remained resistant, Gram-positive <i>Staphylococcus epidermidis</i> was effectively suppressed by photodynamic therapy (PDT), and Hyp/PEN co-delivery overcame bacterial resistance to PEN. These results highlight MIL-101(Al)-NH<sub>2</sub> as a multifunctional nanoplatform with immunostimulatory capacity and PDT-enhanced antibacterial activity, offering a promising strategy to combat antibiotic resistance and infections associated with medical implants.
Authors
- Mariana Máčajová (ORCID: https://orcid.org/0000-0002-4034-6001)
- Boris Bilčı́k (ORCID: https://orcid.org/0000-0002-9933-5147)
- Miroslav Almáši (ORCID: https://orcid.org/0000-0002-6044-6683)
- Erik Sedlák (ORCID: https://orcid.org/0000-0003-1290-5774)
- Ľuboš Ambro (ORCID: https://orcid.org/0000-0003-4398-1665)
- Gabriela Zelenková (ORCID: https://orcid.org/0000-0002-7664-8802)
- Veronika Huntošová (ORCID: https://orcid.org/0000-0003-0042-2097)
- Ivan Čavarga (ORCID: https://orcid.org/0009-0008-3640-3625)
- Ľuboš Zauška (ORCID: https://orcid.org/0000-0003-2865-2927)
- Majlinda Meta (ORCID: https://orcid.org/0000-0003-0947-6569)
- Terézia Gulyásová
Institutions
- University of Ostrava (CZ)
- University of Pavol Jozef Šafárik (SK)
- Institute of Animal Biochemistry and Genetics of the Slovak Academy of Sciences (SK)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2025-12-02
- DOI
- https://doi.org/10.3390/ijms262311681
- Citations
- 1
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.67